Tissue-engineered Skin Graft Repair of Autologous Scar Dermal Scaffolds
NCT04389164 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 226
Last updated 2020-05-15
Summary
Hypertrophic scar is an inevitable outcome of wound repair. It affects the appearance and some scar contracture often leads to joint dysfunction.Patients have low quality of life, long treatment cycle, heavy social burden and high medical costs.Skin grafting is currently the gold standard for scar repair.However, there are often insufficient skin sources, easy to scar recurrence, lack of skin accessory organs.The application of composite skin graft can reduce the recurrence rate of scar healing and relieve the deficiency of skin source.However, its survival rate is not high, and acellular allogeneic dermal scaffolds are expensive, heavy medical burden.Therefore, how to effectively repair the wound surface after surgical excision of scar is the main problem to be solved urgently.
Dermal loss is the main cause of unsatisfactory scar repair and recurrence.The previous clinical study of the research group found that the application of autologous epidermal basal cells and autologous skin graft obtained in real time during the operation could effectively improve the survival rate of skin graft in the treatment of wound surface (Brit J Surg, 2015).Furthermore, it is suggested that the application of autologous scar dermal scaffolds can achieve the control of skin damage in the skin harvesting area and the orthotopic transplantation of autologous scar tissue dermal scaffolds, which can effectively reduce the economic burden of patients.Therefore, the researchers wondered whether the construction of tissue-engineered skin orthotopic transplantation with autologous epidermal basal cells and autologous scar dermal scaffold combined with autologous scar dermal scaffolds to repair the wound after scar resection could improve the survival rate of skin graft and reduce scar recurrence.To this end, we plan to carry out multi-center, prospective, randomized, controlled clinical trials, aiming at proposing more effective surgical treatment guidelines for the repair of hypertrophic scar, improving the survival rate of composite skin graft, and solving the current clinical problems of hypertrophic scar repair.
Conditions
- Scar
Interventions
- PROCEDURE
-
Tissue-engineered skin grafts of autologous scar dermal scaffolds
1. scar excision. The thickness of scar tissue in the middle of scar is removed with a roller cutter and the thickness is about 0.01 -- 0.02mm. 2. take autologous skin slices of the patient with an electric skin knife, cut out a small piece of skin, and prepare autologous epidermal basal cell suspension for use;The rest of the skin should be the same size as the wound. 3. the prepared autogenous scar dermal stent was grafted onto the scar resection wound surface, and the prepared autoepidermal basal cells were sprayed between the mesh and on the dermal stent, and autologous skin slices were grafted onto the wound surface and fixed with pressure bandaging; 4. after the operation, the outer dressing should be changed regularly according to the conventional treatment, and the wound surface condition should be observed and recorded according to the experimental scheme.
Sponsors & Collaborators
-
First Affiliated Hospital, Sun Yat-Sen University
lead OTHER
Principal Investigators
-
ZHU JIAYUAN · Professor, chief physician
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-01
- Primary Completion
- 2025-12-31
- Completion
- 2027-12-31
Countries
- China
Study Locations
More Related Trials
-
Evaluation of the Effect of CGF in Promoting Mechanical-stretch Induced in Vivo Skin Regeneration
NCT03406143 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Use of Minced Skin Grafts for Promoting Donor Site Wound Healing After Split-Thickness Skin Grafting
NCT06488612 ·Status: RECRUITING ·Phase: NA
-
Microsurfaced Grafts in Deep Burn Wounds
NCT04589442 ·Status: RECRUITING ·Phase: PHASE4
-
Autologous Point-of-Care Adipose Therapy: Delayed Injury/Scar
NCT06857435 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Autologous Keratinocyte Suspension Versus Adipose-Derived Stem Cell-Keratinocyte Suspension for Post-Burn Raw Area
NCT03686449 ·Status: UNKNOWN ·Phase: NA
-
Fractional Microneedling RF vs Intralesional Steroid With & Without Microneedling in Hypertrophic Scars
NCT04389619 ·Status: UNKNOWN ·Phase: NA
-
The Comparison of Thick Split-thickness Skin Graft Versus Thin Split-thickness Skin Graft
NCT05571904 ·Status: UNKNOWN ·Phase: NA
-
Wound-healing Improvement by Resurfacing Split-Thickness Skin Donor Sites With Thin Split-thickness Grafting
NCT01974583 ·Status: COMPLETED
-
The Dermisgraft Epithelialization and Late Scar Healing
NCT05189743 ·Status: COMPLETED ·Phase: NA
-
The Development and Application of "Scar-care" Padding on Management of Hypertrophic Scar
NCT03469830 ·Status: COMPLETED ·Phase: NA
-
Retrospective Analysis of Spray Skin Treats for Severe Burns
NCT06170424 ·Status: COMPLETED
-
Autologous Epidermal Cell Treat for Nonhealing Postoperative Wound
NCT06173908 ·Status: RECRUITING ·Phase: NA
-
Feasibility Study for Fibroblast Autologous Skin Grafts
NCT01964859 ·Status: RECRUITING ·Phase: PHASE2
-
Biological Skin Graft With Keratinocyte-stem Cell Co-cultre for Burn Patients
NCT05652816 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Mesenchymal Stem Cell-derived Pleiotropic Factor in the Treatment of Donor Sites
NCT04234750 ·Status: UNKNOWN ·Phase: PHASE1
-
A Trial to Evaluate the Combination Efficacy of Artificial Dermis and Growth Factor in Chronic Wounds Ulcer
NCT04132635 ·Status: UNKNOWN ·Phase: NA
-
Amplification of Autologous Epidermal Cells to Repair Large Area Deep Wounds
NCT05882110 ·Status: RECRUITING ·Phase: NA
-
Research on the Key Technology of Burn Wound Treatment
NCT03279549 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Stromal Vascular Fraction Transplantation on the Regeneration of Expanded Skin
NCT07114692 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Scarring in Stratagraft-treated vs. Autograft-treated Burn Wounds: a Clinical and Histological Investigation
NCT04896346 ·Status: UNKNOWN
-
Autologous Point-of-Care Adipose Therapy: Recent Injury
NCT06857448 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Mesenchymal Stem Cell Conditioned Medium-derived Pleiotropic Factor in Treating Residual Burn Wound
NCT04235296 ·Status: UNKNOWN ·Phase: PHASE1
-
Non-cultured Autologous Keratinocyte Suspension Versus Traditional Split Skin Graft for Burn Wounds Treatment
NCT03675568 ·Status: WITHDRAWN ·Phase: NA
-
Evaluation of the Postoperative Effect of Expanded Pedicled Deltopectoral Flap to Repair the Facial-Cervical Scars
NCT03735641 ·Status: UNKNOWN
-
Long Term Evaluation of Human Acellular Dermal Matrix Allograft For Coverage of the Wound After Extensive Deep Burn
NCT01562119 ·Status: UNKNOWN